SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant volatility and trending momentum as investors closely monitor upcoming blockchain upgrades and potential token burn events. The community remains deeply divided, with many traders speculating on a supply shock and potential price recovery while skeptics warn of pump-and-dump risks.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as community members aggressively debate whether the token is primed for a new all-time high or if it is entering a period of exhaustion. Bullish traders are actively calling for others to hold through dips and push for higher volume, while skeptics warn of potential rug pulls and shift their attention to emerging meme coins.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The $ROAR token is seeing intense community-driven momentum as investors draw parallels between its community-led project model and the broader GameStop market sentiment. Discussions are dominated by speculation regarding potential exchange listings and the ongoing strength of the Roaring Kitty narrative, with holders emphasizing the project's decentralized, community-owned structure.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as investors react to the companys recent announcement regarding the preliminary Phase 3 trial design for CAD-1005 in patients with Heparin-Induced Thrombocytopenia. While some community members are highlighting the clinical pipeline and long-term potential of the company's anti-thrombotic programs, others are actively debating concerns regarding share dilution and the heavy volume of automated posts surrounding the stock.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is generating strong community interest driven by its position as a key infrastructure layer for AI-integrated blockchain applications and its rising utility in cross-chain intents. Traders are actively discussing the protocol's fundamental strength and price compression as a potential setup for an upward breakout.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

The JPMorgan Equity Premium Income ETF ($JEPI) remains a central focus for income-oriented investors, with recent community sentiment driven by its ability to provide monthly cash flow distributions amid broader market volatility. Investors are actively discussing the strategy's utility as a portfolio stabilizer and income generator, often comparing it to $JEPQ and other derivative-income funds to evaluate trade-offs between yield, tax treatment, and capital preservation.

Crexendo, Inc. engages in the provision of telecommunications services, broadband Internet services, and other cloud business services. It operates through the Cloud Telecommunications Services and Software Solutions segments. The Cloud Telecommunications Services segment focuses on selling cloud telecommunication products and services and broadband Internet services. The software solutions segment focuses on software licenses, software maintenance support and professional services. The company was founded on April 13, 1995 and is headquartered in Tempe, AZ.

Crexendo Inc

Crexendo is seeing significant community interest driven by consistent earnings beats and the company's expanding market share in the UCaaS space, particularly as competitors like Cisco and Microsoft shift their focus away from similar platforms. Investors are closely monitoring its recurring revenue growth, AI-powered feature integrations, and potential for future accretive acquisitions as the firm cements its position in the cloud communications market.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter's UPDOG token is generating significant community buzz, with supporters highlighting its two-year presence on the Solana network and inclusion on the Jupiter Strict List. While some market participants express skepticism regarding its legitimacy, the community remains actively engaged in promotional efforts and liquidity-focused initiatives.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community maintains a patient, long-term outlook, frequently discussing the project's 'move-to-earn' utility and potential for a future breakout. Despite recent downward pressure, many supporters are actively accumulating while highlighting their commitment to the ecosystem's long-term growth and fitness-focused mission.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant investor attention as it prepares for a high-profile oral presentation at Digestive Disease Week, where community members anticipate the release of compelling clinical data on pancreatic cancer. The stock is currently trending due to a combination of clinical trial progress and institutional accumulation, with many investors expressing optimism about its potential for long-term growth and upcoming catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

InnovAge Holding Corp. (NASDAQ:INNV) Sees Significant Growth in Short Interest

InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report) was the target of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 701,414...

InnovAge (INNV) to Release Quarterly Earnings on Tuesday

InnovAge (NASDAQ:INNV) will be releasing its Q3 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...

Organon (OGN) Soars 30.9%: Is Further Upside Left in the Stock?

Organon (OGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

HCA Healthcare Q1 Earnings Miss Estimates on Rising Expenses

HCA's Q1 EPS misses estimates as rising expenses and weaker surgeries weigh despite modest revenue growth and gains in ER visits.

ELV Beats Q1 Earnings Estimates on Rising Net Investment Income

Elevance Health beats Q1 EPS estimates as net investment income jumps 29.7%, offsetting membership decline and higher expenses.

UnitedHealth Q1 Earnings Beat Estimates on Rising Premiums

UNH tops Q1 EPS on strong commercial fee-based membership and Optum Rx despite Optum Health weakness and declining risk-based membership.

165,066 Shares in InnovAge Holding Corp. $INNV Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management purchased a new position in InnovAge Holding Corp. (NASDAQ:INNV - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 165,066 shares of the company's stock, valued at ap...

InnovAge Holding Corp. (NASDAQ:INNV) Short Interest Up 72.6% in March

InnovAge Holding Corp. (NASDAQ:INNV - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totaling 572,966 shares...

Humana Bets on Pharmacists to Lift Chronic Care Outcomes

HUM taps pharmacists via a value-based program in Ohio to boost hypertension and diabetes outcomes while aiming to curb costs and improve care access.

Why Teladoc Deserves Patience Now: Too Early to Buy, Too Risky to Sell

TDOC trades at a discount as Teladoc expands AI-driven care, cuts costs, and eyes better profitability, but BetterHelp weakness and rising competition cloud outlook.

InnovAge Holding Corp. engages in managing the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The company program is dedicated to enabling older adults to age independently in their own homes for as long as safely possible. It offers interdisciplinary care teams and community-based care delivery models. The company was founded in May 2007 and is headquartered in Denver, CO.

Current Price	$8.32
Prev Close	$8.15
Open	$8.17
Dividend Yield	0.00%
50-Day Moving Average	$8.37
Beta	1.23
Avg. Volume	233,902.64
PE Ratio	178.92

52-Week High	$10.69
52-Week Low	$2.84
Market Capitalization	$1.13B
EPS (Annual)	-$0.2239
Price to Book	4.40
Revenue Per Employee	$349,876.64

INNV
InnovAge Holding Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INNV News

INNVInnovAge Holding Corp